sermorelin-ipamorelin Sermorelin - Research Peptide SERMORELIN/IPAMORELIN - Houston Men's Health

Human studies In a multicenter, randomized, double-blinded, placebo controlled phase II study (ClinicalTrials.gov Identifier: NCT00889486) oral administration of TZP-102 once daily for 28-days demonstrated significant improvements in the most prevalent symptoms of gastroparesis in diabetic patients (43)

Yet, ipamorelin is more selective in its GH-stimulating effects and does not influence other pituitary hormone levels

Real Peptides manufactures ipamorelin exclusively as lyophilised powder for injection because bioavailability and molecular stability are non-negotiable variables in research-grade peptide protocols

It signals your pituitary gland to produce and release GH, supporting fat loss, muscle growth, and energy